Testing effectiveness (Phase 2)Study completedNCT00110617
What this trial is testing
Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
Who this might be right for
Sickle Cell DiseaseIron OverloadHemolytic Anemia
Novartis Pharmaceuticals 212